Visium Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Visium Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-15,035	Closed	-$124K	–	1376
2015 Q1	$124K	Buy	+15,035	New	+$111K	﹤0.01%	964
2014 Q4	–	Sell	-188,748	Closed	-$1.02M	–	1286
2014 Q3	$1.02M	Buy	188,748 +169,298	+870%	+$989K	0.02%	587
2014 Q2	$124K	Buy	+19,450	New	+$134K	﹤0.01%	1019
2014 Q1	–	Sell	-16,127	Closed	-$110K	–	1104
2013 Q4	$110K	Sell	16,127 -738,029	-98%	-$3.98M	﹤0.01%	842
2013 Q3	$13.9M	Buy	+754,156	New	+$14.6M	0.31%	67

Other funds holding ARIA

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Visium Asset Management's ARIA Position: Q2 2015 in Review

Visium Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2015, closing a stake of 15,035 shares — an estimated $124K sold.

Visium Asset Management first reported a position in ARIA in Q3 2013 and held it in 5 quarters. The position peaked at $13.9M in Q3 2013. 177 funds tracked by Wall St. Rank hold ARIA as of Q2 2015.

Visium Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2015 after selling out during the quarter.
Visium Asset Management sold 15,035 Ariad Pharmaceuticals Inc shares in Q2 2015, an estimated $124K.
Visium Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 5 quarters.
Visium Asset Management's Ariad Pharmaceuticals Inc position peaked at $13.9M in Q3 2013.
177 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2015.

Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.